Reuters Market Eye - Shares in Sun Pharmaceutical Industries Ltd
Analysts tracking the sector say the leading brand in this segment is Taro's Topicort, which had annual sales of $50 million.
Also, Citigroup in a report says while Taro has also lost market share in its largest product Nystatin/Triam combo, it could see more competition in some of its other products.
(Reporting by Abhishek Vishnoi)